Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 92

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 92
---
 Company   
 of any or all of the B Deferred Shares. The terms of such contract shall provide for payment in full of the purchase price upon completion  
 and may require the holders of the B Deferred Shares concerned to sell such shares for a price not exceeding 1 penny for all the B Deferred 
 Shares so purchased. If such a resolution is passed and the Company is in all other respects able and willing to purchase the B Deferred    
 Shares to which the contract relates in accordance with Sections 690 to 708 of the Act, the Company shall have irrevocable authority to     
 appoint any person: (i) to execute such contract on behalf of each of the holders of the relevant B Deferred Shares; (ii) to execute a      
 stock transfer form (or forms) sufficient in every respect to transfer to the Company the legal title to the B Deferred Shares that are     
 the subject of such contract, and (iii) to receive at completion the purchase price on behalf of the holders of the B Deferred Shares.      
 From the time that such resolution is passed, the holders of the B Deferred Shares that are the subject of such contract shall hold such    
 shares as bare trustee for the Company.                                                                                                     |

| 144.3 | -A | Subject to the Act, the Company may, at its option, cancel B Deferred Shares by way of a reduction of 
 capital for no consideration; and/or                                                                  |

| (B) | Pending any such transfer and/or purchase and/or cancellation, the Company may retain any share certificate 
 that may be issued in respect of any of the B Deferred Shares.                                              |

| 145 | C DEFERRED SHARES |

| 145.1 | The following rights and restrictions shall be attached to the C Deferred Shares of £0.00005 each: |

| (A) | As regards income |

The holders of the C Deferred Shares
shall not be entitled to receive any dividend or any other distribution out of the profits of the Company including, without limitation,
any allotment (whether or not fully paid) as a result of the capitalisation of any sum standing to the credit of any share premium account
or of any reserve (whether or not available for distribution) of the Company;

| 69 |

| (B) | As regards voting |

The holders of the C Deferred Shares
shall not be entitled to receive notice of or to attend or speak (either personally or by proxy) at any general meeting of the Company
or to vote (either personally or by proxy) on any resolution to